Table 3. Percentage of patients with elevated levels of LDH, CRP, and D-Di in different immune statuses and different vaccination scenarios.
* Using the chi-square test, P < 0.05 indicates statistical significance.
P1: significance of the unvaccinated group compared to the vaccinated group; P2: significance of the ≧1 group compared to the <1 group, P3: significance of comparison of groups A and C; P4: significance of comparison of groups B and D.
≧1: patient's lymphocyte count on admission ≧1 (10^9/L); <1: patient's lymphocyte count on admission <1 (10^9/L).
LDH: lactate dehydrogenase; CRP: C-reactive protein; D-Di: D-dimer.
| Laboratory test | Total (n = 338) | Unvaccinated (n = 117) | Vaccinated (n = 221) | ≧1 (n = 159) | <1 (n = 179) | Group | P1 | P2 | P3 | P4 | |||
| Unvaccinated | Vaccinated | ||||||||||||
| ≧1 | <1 | ≧1 | <1 | ||||||||||
| A (n =51) | B (n = 66) | C (n = 108) | D (n = 113) | ||||||||||
| LDH (U/L), n (%) | 0.171 | 0.028 | 0.144 | 0.709 | |||||||||
| 0-225 | 153 (45.30) | 47 (40.2) | 106 (48.0) | 82 (51.6) | 71 (39.7) | 22 (43.10) | 25 (37.90) | 60 (55.60) | 46 (40.70) | ||||
| >225 | 185 (54.70) | 70 (59.8) | 115 (52.0) | 77 (48.4) | 108 (60.3) | 29 (56.90) | 41 (62.10) | 48 (44.40) | 67 (59.30) | ||||
| CRP (mg/L), n (%) | 0.025 | 0.048 | 0.262 | 0.055 | |||||||||
| 0-10 | 128 (38.32) | 35 (29.9) | 93 (42.1) | 69 (43.4) | 59 (33.0) | 19 (37.25) | 16 (24.20) | 50 (46.30) | 43 (38.10) | ||||
| >10 | 210 (62.10) | 82 (70.1) | 128 (57.9) | 90 (56.6) | 120 (67.0) | 32 (62.75) | 50 (75.80) | 58 (53.70) | 70 (61.90) | ||||
| D-Di (mg/L), n (%) | 0.003 | 0.002 | 0.091 | 0.012 | |||||||||
| 0-550 | 107 (31.70) | 23 (19.7) | 84 (38.0) | 66 (41.5) | 41 (22.9) | 15 (29.41) | 8 (12.10) | 51 (47.20) | 33 (29.20) | ||||
| >550 | 231 (68.30) | 94 (80.3) | 137 (62.0) | 93 (58.5) | 138 (77.1) | 36 (70.59) | 58 (87.90) | 57 (52.80) | 80 (70.80) | ||||